Animals bearing hypomorphic SMN point mutations that cause milder forms of SMA complete development and display normal snRNP levels, but still exhibit neuromuscular defects (Garcia et al., 2016; Spring et al., 2019). The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.